Truncated interleukin-1 receptor gene for the treatment of...

C - Chemistry – Metallurgy – 12 – N

Patent

Rate now

  [ 0.00 ] – not rated yet Voters 0   Comments 0

Details

C12N 15/25 (2006.01) A61K 31/70 (2006.01) A61K 35/32 (2006.01) A61K 38/20 (2006.01) A61K 48/00 (2006.01) C07H 21/00 (2006.01) C07K 14/715 (2006.01) C12N 5/10 (2006.01) C12N 15/867 (2006.01) A61K 38/00 (2006.01)

Patent

CA 2098848

2098848 9211359 PCTABS00014 The subject invention concerns a method of using in vivo a gene encoding an extracellular interleukin-1 binding domain of an interleukin-1 receptor that is capable of binding to and neutralizing interleukin-1 which includes employing recombinant techniques to produce a cell line under the control of a suitable eukaryotic promoter having the gene coding for the extracellular interleukin-1 binding domain of the interleukin-1 receptor; and initiating transfection of DNA of the gene by introducing viral particles obtained from the cell line directly into synovial cells lining a joint space of a mammalian host. Alternatively, synovial cells from the patient's joint may be transduced with the retroviral vector carrying the therapeutic gene and a selectable marker for selection of only transduced cells, and the now therapeutic autologous cells may be introduced back into the joint by transplantation. Additionally, a method of preparing a gene encoding an extracellular interleukin-1 receptor binding domain of an interleukin-1 that is capable of binding to and neutralizing interleukin-1 is disclosed. A compound for parenteral administration to a patient in prophylactically or therapeutically effective amounts containing the gene of the invention and a suitable pharmaceutical carrier is also provided.

LandOfFree

Say what you really think

Search LandOfFree.com for Canadian inventors and patents. Rate them and share your experience with other people.

Rating

Truncated interleukin-1 receptor gene for the treatment of... does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Truncated interleukin-1 receptor gene for the treatment of..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Truncated interleukin-1 receptor gene for the treatment of... will most certainly appreciate the feedback.

Rate now

     

Profile ID: LFCA-PAI-O-1543875

  Search
All data on this website is collected from public sources. Our data reflects the most accurate information available at the time of publication.